High, Katherine A.
Spark Therapeutics (United States)
56 papers on CoChatORCID 0000-0002-0805-6223
Most cited papers
- Verified
AAV-1–mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells
Mingozzi, F., Meulenberg, J. J., Hui, D. J., Basner-Tschakarjan, E., Hasbrouck, N. C., Edmonson, S. A., Hutnick, N. A., Betts, M. R., Kastelein, J. J., Stroes, E. S., et al. (2009) · Blood
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 295
- Verified
Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant
McIntosh, J., Lenting, P. J., Rosales, C., Lee, D., Rabbanian, S., Raj, D., Patel, N., Tuddenham, E. G. D., Christophe, O. D., McVey, J. H., et al. (2013) · Blood
Hemophilia Treatment and ResearchVirus-based gene therapy research
Cited by 278
- Verified
Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy
Niemeyer, G. P., Herzog, R. W., Mount, J., Arruda, V. R., Tillson, D. M., Hathcock, J., van Ginkel, F. W., High, K. A., & Lothrop, C. D. (2009) · Blood
Hemophilia Treatment and ResearchVirus-based gene therapy research
Cited by 276
- Verified · note
Reversal of Blindness in Animal Models of Leber Congenital Amaurosis Using Optimized AAV2-mediated Gene Transfer
Bennicelli, J., Wright, J. F., Komaromy, A., Jacobs, J. B., Hauck, B., Zelenaia, O., Mingozzi, F., Hui, D., Chung, D., Rex, T. S., et al. (2008) · Molecular Therapy
Retinal Development and DisordersVirus-based gene therapy research
Cited by 267
- Verified
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver
Mingozzi, F., Hasbrouck, N. C., Basner-Tschakarjan, E., Edmonson, S. A., Hui, D. J., Sabatino, D. E., Zhou, S., Wright, J. F., Jiang, H., Pierce, G. F., et al. (2007) · Blood
Virus-based gene therapy researchHemophilia Treatment and Research
Cited by 254
- Verified
Long-term follow-up of the first in human intravascular delivery of AAV for gene transfer: AAV2-hFIX16 for severe hemophilia b
George, L. A., Ragni, M. V., Rasko, J. E. J., Raffini, L. J., Samelson-Jones, B. J., Ozelo, M., Hazbon, M., Runowski, A. R., Wellman, J. A., Wachtel, K., et al. (2020) · Molecular Therapy
Virus-based gene therapy researchHemophilia Treatment and Research
Cited by 213
- Verified
Intramuscular Administration of AAV1-Lipoprotein Lipase S447X Lowers Triglycerides in Lipoprotein Lipase–Deficient Patients
Stroes, E. S., Nierman, M. C., Meulenberg, J. J., Franssen, R., Twisk, J., Henny, C. P., Maas, M. M., Zwinderman, A. H., Ross, C., Aronica, E., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology
Lipid metabolism and disordersVirus-based gene therapy research
Cited by 209
- Verified
Overcoming the Host Immune Response to Adeno-Associated Virus Gene Delivery Vectors: The Race Between Clearance, Tolerance, Neutralization, and Escape
Mingozzi, F., & High, K. A. (2017) · Annual Review of Virology
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 206
- Verified · note
Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease
Maguire, A. M., Russell, S., Chung, D. C., Yu, Z.-F., Tillman, A., Drack, A. V., Simonelli, F., Leroy, B. P., Reape, K. Z., High, K. A., et al. (2021) · Ophthalmology
Retinal Development and DisordersRetinal Diseases and Treatments
Cited by 194
- Verified
Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectors
Pien, G. C., Basner-Tschakarjan, E., Hui, D. J., Mentlik, A. N., Finn, J. D., Hasbrouck, N. C., Zhou, S., Murphy, S. L., Maus, M. V., Mingozzi, F., et al. (2009) · Journal of Clinical Investigation
Virus-based gene therapy researchImmunotherapy and Immune Responses
Cited by 192
- Verified
Muscle-Directed Gene Transfer and Transient Immune Suppression Result in Sustained Partial Correction of Canine Hemophilia B Caused by a Null Mutation
Herzog, R. W., Mount, J. D., Arruda, V. R., High, K. A., & Lothrop, C. D. (2001) · Molecular Therapy
Hemophilia Treatment and ResearchVirus-based gene therapy research
Cited by 176
- Verified
Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells
Martino, A. T., Basner-Tschakarjan, E., Markusic, D. M., Finn, J. D., Hinderer, C., Zhou, S., Ostrov, D. A., Srivastava, A., Ertl, H. C. J., Terhorst, C., et al. (2013) · Blood
Virus-based gene therapy researchHemophilia Treatment and Research
Cited by 162
- Verified
Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapy
Herzog, R. W., Fields, P. A., Arruda, V. R., Brubaker, J. O., Armstrong, E., McClintock, D., Bellinger, D. A., Couto, L. B., Nichols, T. C., & High, K. A. (2002) · Human Gene Therapy
Hemophilia Treatment and ResearchVirus-based gene therapy research
Cited by 147
- Verified
Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindness
Amado, D., Mingozzi, F., Hui, D., Bennicelli, J. L., Wei, Z., Chen, Y., Bote, E., Grant, R. L., Golden, J. A., Narfstrom, K., et al. (2010) · Science Translational Medicine
Retinal Development and DisordersVirus-based gene therapy research
Cited by 140
- Verified
Prevalence and pharmacological modulation of humoral immunity to AAV vectors in gene transfer to synovial tissue
Mingozzi, F., Chen, Y., Edmonson, S. C., Zhou, S., Thurlings, R. M., Tak, P. P., High, K. A., & Vervoordeldonk, M. J. (2013) · Gene Therapy
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 138
- Verified
Risk and Prevention of Anti-factor IX Formation in AAV-Mediated Gene Transfer in the Context of a Large Deletion of F9
Fields, P. A., Arruda, V. R., Armstrong, E., Chu, K., Mingozzi, F., Hagstrom, J. N., Herzog, R. W., & High, K. A. (2001) · Molecular Therapy
Hemophilia Treatment and ResearchVirus-based gene therapy research
Cited by 127
- Verified
Effective gene therapy for haemophilic mice with pathogenic factor IX antibodies
Markusic, D. M., Hoffman, B. E., Perrin, G. Q., Nayak, S., Wang, X., LoDuca, P. A., High, K. A., & Herzog, R. W. (2013) · EMBO Molecular Medicine
Hemophilia Treatment and ResearchVirus-based gene therapy research
Cited by 116
- Verified
Proteasome Inhibitors Decrease AAV2 Capsid derived Peptide Epitope Presentation on MHC Class I Following Transduction
Finn, J. D., Hui, D., Downey, H. D., Dunn, D., Pien, G. C., Mingozzi, F., Zhou, S., & High, K. A. (2010) · Molecular Therapy
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 115
- Verified
Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid
Vercauteren, K., Hoffman, B. E., Zolotukhin, I., Keeler, G. D., Xiao, J. W., Basner-Tschakarjan, E., High, K. A., Ertl, H. C., Rice, C. M., Srivastava, A., et al. (2016) · Molecular Therapy
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 114
- Verified
Pharmacological modulation of humoral immunity in a nonhuman primate model of AAV gene transfer for hemophilia b
Mingozzi, F., Chen, Y., Murphy, S. L., Edmonson, S. C., Tai, A., Price, S. D., Metzger, M. E., Zhou, S., Wright, J. F., Donahue, R. E., et al. (2012) · Molecular Therapy
Virus-based gene therapy researchHemophilia Treatment and Research
Cited by 112
- Verified
Diverse IgG subclass responses to adeno‐associated virus infection and vector administration
Murphy, S. L., Li, H., Mingozzi, F., Sabatino, D. E., Hui, D. J., Edmonson, S. A., & High, K. A. (2009) · Journal of Medical Virology
Virus-based gene therapy researchMonoclonal and Polyclonal Antibodies Research
Cited by 101
- Verified
Gene therapy for the hemophilias
Kay, M. A., & High, K. (1999) · Proceedings of the National Academy of Sciences
Hemophilia Treatment and ResearchVirus-based gene therapy research
Cited by 96
- Verified
Impact of AAV Capsid-Specific T-Cell Responses on Design and Outcome of Clinical Gene Transfer Trials With Recombinant Adeno-Associated Viral Vectors: An Evolving Controversy
Ertl, H. C. J., & High, K. A. (2017) · Human Gene Therapy
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 94
- Verified
Impact of the Underlying Mutation and the Route of Vector Administration on Immune Responses to Factor IX in Gene Therapy for Hemophilia B
Cao, O., Hoffman, B. E., Moghimi, B., Nayak, S., Cooper, M., Zhou, S., Ertl, H. C., High, K. A., & Herzog, R. W. (2009) · Molecular Therapy
Hemophilia Treatment and ResearchVirus-based gene therapy research
Cited by 92
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free